Stocks股票 / Health Care / RGEN
Repligen · Health Care
RGEN US listed · USD美股 · 美元
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.Repligen Corporation是一家美国生命科学公司，致力于开发和制造用于生物药物生产的产品。公司总部位于马萨诸塞州沃尔瑟姆，在纳斯达克上市，股票代码为RGEN。
Mid cap中盘 · $8B
Rate-sensitive利率敏感
Health Care
S&P 400标普400中盘
$145.49
-$1.76 · -1.20%
52w low52周低 $99.65high高 $176
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Stretched/late — protect gains and don't start new positions; let the next low set up first.已拉伸／晚期——保护利润，不要新开仓；先等下一个低点构筑成形。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
60
Elevated偏高
vs 50-day average相对50日均线
+13.0% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+3.8% above上方
Long trend up长期向上
Volatility波动率
80th percentile第80百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0415days to go天后公布
Estimates being cut预期下调
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | RGEN | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 167.60x | 28.59 | |
| P/B市净率 | 3.89x | 3.44 | |
| Earnings yield盈利收益率 | 0.60% | 2.72 | |
| FCF yield自由现金流收益率 | 1.15% | 4.00 | |
| Shareholder yield股东收益率 | 0.00% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 61.02x | 18.18 | |
| P/FCF市值/自由现金流 | 87.27x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 15.0%
Earnings per share每股收益
5-yr growth5年复合增速 -5.0%
Free cash flow自由现金流
Operating margin营业利润率
7.5%
Balance-sheet quality财务体质 6/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 2%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.18
Current ratio流动比率8.37
Capital allocation资本配置
Stock-based comp股权薪酬$32.6M
Share count change (1y)股数变化（1年）+0.4%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
RGEN daily MACD crossed downRGEN 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$8.6M net (0 buyers, 4 sellers)-$8.6M 净值（0 买家，4 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Adding加仓 | 1.4% | 2026-03-31 |
| Perceptive Advisors | A | trimtrim | 0.7% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS. Late in the daily cycle (day 43 of ~23-44) — odds favor a dip into the next cycle low from here even with the trend intact止盈。处于日线周期晚期（约 23-44 天中的第 43 天）——即便趋势完好，从此处概率上仍倾向于回落至下一个周期低点
Jul 20, 2026
RGEN daily MACD crossed downRGEN 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $145.49.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$145.49。
Jul 10, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 10, 2026
RGEN daily MACD crossed upRGEN 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $144.24.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$144.24。
Jul 9, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 9, 2026
RGEN reclaimed its 200-day averageRGEN 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $143.94.收盘重回200日均线 — 经典的多头分界线。$143.94。
Jul 9, 2026
RGEN took relative-strength leadershipRGEN 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $143.94.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$143.94。
Jul 8, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
RGEN lost its 200-day averageRGEN 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $137.41.收盘跌破200日均线 — 经典的空头分界线。$137.41。
Jul 8, 2026
RGEN daily MACD crossed downRGEN 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $137.41.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$137.41。
Jul 6, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 2, 2026
RGEN took relative-strength leadershipRGEN 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $142.40.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$142.40。
Jul 1, 2026
RGEN reclaimed its 200-day averageRGEN 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $138.99.收盘重回200日均线 — 经典的多头分界线。$138.99。
Showing the last 15 of显示最近15条，共 235 signals条信号
Company profile公司档案
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN.Repligen Corporation是一家美国生命科学公司，致力于开发和制造用于生物药物生产的产品。公司总部位于马萨诸塞州沃尔瑟姆，在纳斯达克上市，股票代码为RGEN。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 167.6× | 28.6× | 3% |
| Price / Book市净率 | 3.9× | 3.4× | 43% |
| EV / EBITDAEV/EBITDA | 61.0× | 18.2× | 9% |
| Earnings yield盈利收益率 | 0.6% | 2.7% | 28% |
| Free-cash-flow yield自由现金流收益率 | 1.4% | 5.5% | 12% |
| Shareholder yield股东综合回报率 | 0.0% | 1.9% | 6% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
44/100 — middle of the pack居中
vs market, 3 months相对大盘（3个月）
71/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
26/100 — weaker than most弱于多数
vs market, 12 months相对大盘（12个月）
58/100 — middle of the pack居中
Rank in sector行业内排名
#106 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.4% | -0.9% |
| 1 Month近1月 | +10.2% | -0.6% |
| 3 Months近3月 | +9.6% | +5.4% |
| 6 Months近6月 | -14.4% | +8.6% |
| Year to date年初至今 | -11.5% | +8.9% |
| 1 Year近1年 | +25.2% | +19.2% |
| 3 Years近3年 | -17.0% | +69.9% |
Trading information交易信息
Beta vs market贝塔
1.21
Volatility rank波动率分位
80th pctile
Short interest空头占比
10.7% of float
Market cap市值
$8B
EPS (trailing)每股收益
$0.87
Off 52-week high距52周高点
-15.5%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $366M | $671M | $802M | $632M | $634M | $738M |
| EPS每股收益 | $1.11 | $2.24 | $3.24 | $0.63 | $-0.46 | $0.86 |
| Free cash flow自由现金流 | $40M | $52M | $87M | $78M | $150M | $94M |
| Gross margin毛利率 | 57.2% | 58.3% | 56.9% | 44.0% | 43.3% | 52.3% |
| Net margin净利率 | 16.4% | 19.1% | 23.2% | 5.6% | -4.0% | 6.6% |
| FCF margin自由现金流利润率 | 11.0% | 7.7% | 10.9% | 12.3% | 23.6% | 12.7% |
Latest fiscal year最近财年
Net income净利润
$49M
Operating cash flow经营现金流
$117M
Total assets总资产
$2.9B
Shareholder equity股东权益
$2.1B
Buybacks股票回购
$0
Shares outstanding总股本
0.06B
Returns & growth回报与增长
Return on equity股本回报率
2.3%
Return on assets资产回报率
1.7%
Asset growth资产增速
+4.2%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Pricing power: gross margin −4.9pts over 6 years定价能力：毛利率 6 年下降 4.9 个百分点
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: Altman Z 6.76 — safe zone资产负债表：Altman Z 6.76——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
60
RSI (2-day)RSI（2日）
16
vs 20-day average相对20日均线
+2.9%
vs 50-day average相对50日均线
+13.0%
vs 200-day average相对200日均线
+3.8%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down — fresh downturn动能向下——刚刚转弱
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
50/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
3
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
+1.6%
Net upgrades, 30 days净上调（30天）
-1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RTW Investments | B | Adding增持 | 1.4% | $142M |
| Perceptive Advisors | A | Trimming减持 | 0.7% | $33M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
1 : 1
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 9, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2024-06-30', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2024-08-12', 'holders_series': [1, 1, 1, 2, 2, 1, 2, 2, 0]}{'direction': 'distributing', 'n_quarters': 9, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2024-06-30', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2024-08-12', 'holders_series': [1, 1, 1, 2, 2, 1, 2, 2, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$8.6M
Insider buyers vs sellers内部人买家vs卖家
0 : 4
Short interest空头占流通盘
10.7%
Days to cover回补天数
4.7
Short interest change空头变化
+5.6%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Nov · 100%
Weakest month最弱月份
Mar · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 67% | +5.8% | 3 |
| Feb2月 | 33% | -3.5% | 3 |
| Mar3月 | 0% | -7.8% | 3 |
| Apr4月 | 67% | +1.7% | 3 |
| May5月 | 33% | -9.0% | 3 |
| Jun6月 | 50% | +5.6% | 4 |
| Jul7月 | 75% | +20.1% | 4 |
| Aug8月 | 67% | +1.8% | 3 |
| Sep9月 | 33% | -0.7% | 3 |
| Oct10月 | 33% | -9.6% | 3 |
| Nov11月 | 100% | +14.4% | 3 |
| Dec12月 | 33% | -3.8% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。